Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs
Abstract Background Moxidectin has previously shown limited efficacy (≤ 44.4%) against confirmed macrocyclic lactone (ML)-resistant Dirofilaria immitis strains at 3 µg/kg after single and multiple oral dosages. Three studies were conducted to evaluate higher oral moxidectin doses for efficacy agains...
Main Authors: | Tom L. McTier, Robert H. Six, Aleah Pullins, Sara Chapin, Kristina Kryda, Sean P. Mahabir, Debra J. Woods, Steven J. Maeder |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-019-3685-3 |
Similar Items
-
Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs
by: Tom L. McTier, et al.
Published: (2017-11-01) -
ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months
by: Tom L. McTier, et al.
Published: (2019-07-01) -
Safety of Simparica Trio® (sarolaner, pyrantel, moxidectin) in heartworm-infected dogs
by: Sheerin Mathur, et al.
Published: (2023-03-01) -
Efficacy of moxidectin, using various dose regimens, against JYD-34, a macrocyclic lactone resistant isolate of Dirofilaria immitis
by: Elizabeth M. Martin, et al.
Published: (2024-04-01) -
Evaluation of the efficacy of ProHeart® 6 (moxidectin) against a resistant isolate of Dirofilaria immitis (JYD-34) in dogs
by: Dwight D. Bowman, et al.
Published: (2017-11-01)